Olmutinib
Olmutinib is a Novel Epidermal Growth Factor Receptor Tyrosine Kinase InhibitorOlmutinib at 3 μM significantly reversed drug resistance mediated by ABCG2, but not by ABCB1 and ABCC1, by antagonizing the drug efflux function in ABCG2-overexpressing cells.
Product Specifications
CAS Number
1802181-20-9
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
486.6
Molecular Formula
C26H26N6O2S
Notes
Research use only, not for human use.
Receptor
EGFR
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
